NCT01366365View on ClinicalTrials.gov

Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Healthy Adults
Interventions
DRUG

methylnaltrexone

DRUG

placebo

Trial Locations (1)

10591

Progenics Pharmaceuticals, Inc., Tarrytown

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT01366365 - Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide | Biotech Hunter | Biotech Hunter